Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Engcan77on Jun 14, 2019 10:50am

80 Views

Post# 29826083

RE:RE:RE:RE:RE:Really need PR of quality

Yes Cammac. Most of Sirona's news releases leave more questions than answers. This has to change!! Sometimes less is more. When they post Howard's comments, it often creates uncertainty with shareholders. Not done on purpose, but sometimes leaves shareholders thinking does it mean 'this' or 'that's. Not a dig on Howard but they really need to think this through before posting. Or just leave the comments out. They often are not needed. Just my 2 cents

Bullboard Posts

Sirios Resource discovers visible gold in Quebec